Hojnik, M.; Šuster, N.K.; Smrkolj, Š.; Sisinger, D.; Grazio, S.F.; Verdenik, I.; Rižner, T.L.
AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer. Cancers 2022, 14, 809.
https://doi.org/10.3390/cancers14030809
AMA Style
Hojnik M, Šuster NK, Smrkolj Š, Sisinger D, Grazio SF, Verdenik I, Rižner TL.
AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer. Cancers. 2022; 14(3):809.
https://doi.org/10.3390/cancers14030809
Chicago/Turabian Style
Hojnik, Marko, Nataša Kenda Šuster, Špela Smrkolj, Damjan Sisinger, Snježana Frković Grazio, Ivan Verdenik, and Tea Lanišnik Rižner.
2022. "AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer" Cancers 14, no. 3: 809.
https://doi.org/10.3390/cancers14030809
APA Style
Hojnik, M., Šuster, N. K., Smrkolj, Š., Sisinger, D., Grazio, S. F., Verdenik, I., & Rižner, T. L.
(2022). AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer. Cancers, 14(3), 809.
https://doi.org/10.3390/cancers14030809